New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Athira Pharma, Inc.
Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq ・ Market Cap: Micro
Abnormal High-Volume Purchases
CEO Recent Sales
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
TRADES PURCHASE/SALE Sector Average | 2 / 14 2.19 / 7.65 |
INSIDER BUYERS/SELLERS Sector Average | 2 / 5 1.2 / 2.5 |
SHARES PURCHASED/SOLD Transaction Average | 648,086 / 37,995 324,043 / 2,714 |
VALUE PURCHASED/SOLD Transaction Average | $1,534,692 / $78,089 $767,346 / $5,578 |
PURCHASE RANGE | $99,216 - $1,435,475.82 |
SALE RANGE | $725.04 - $14,026.2 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
1 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
100%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.435 0.2 |
VALUE GINI INDEX Sector Average | 0.435 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
38.62%
DIRECTORS
61.38%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.273 0.295 |
VALUE GINI INDEX Sector Average | 0.257 0.288 |
Athira Pharma, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
---|---|---|---|---|---|---|---|---|---|---|
2024-09-05 2024-09-03 | Gengos Andrew | Officer | -$725 | 1,272 | $0.57 | -1.29% | 97,532 | -3.65% | N/A | |
2024-09-05 2024-09-03 | Lenington Rachel | Officer | -$1,439 | 2,525 | $0.57 | -10.79% | 20,870 | -3.65% | N/A | |
2024-09-05 2024-09-03 | CHURCH KEVIN | Officer | -$1,439 | 2,525 | $0.57 | -2.65% | 92,684 | -3.65% | N/A | |
2024-09-05 2024-09-03 | Worthington Mark | Officer | -$1,439 | 2,525 | $0.57 | -4.64% | 51,927 | -3.65% | N/A | |
2024-09-05 2024-09-03 | Litton Mark James | Director | -$2,868 | 5,032 | $0.57 | -2.73% | 179,054 | -3.65% | N/A | |
2024-06-25 2024-06-21 | Romano Kelly A | Director | +$99,216 | 42,400 | $2.34 | +110.66% | 80,715 | +10.05% | +15.07% | |
2024-02-16 2024-01-04 | Litton Mark James | Director | -$14,026 | 4,820 | $2.91 | -2.85% | 164,086 | +9.78% | +9.78% | |
2024-02-16 2024-01-04 | Worthington Mark | Officer | -$7,019 | 2,412 | $2.91 | -6.54% | 34,452 | +9.78% | +9.78% | |
2024-02-16 2024-01-04 | Gengos Andrew | Officer | -$3,515 | 1,208 | $2.91 | -1.42% | 83,804 | +9.78% | +9.78% | |
2024-02-16 2024-01-04 | CHURCH KEVIN | Officer | -$7,019 | 2,412 | $2.91 | -2.92% | 80,256 | +9.78% | +9.78% |